Vinge assisted in a large asset backed funding of consumer loans
November 11, 2009
Vinge assisted the lender and the arranger in connection with a Sweden based NOK 2.4 billion asset backed funding of consumer loans originated by Nordax Finans AB (publ). Vinge's team consisted of Henrik Ossborn, Magnus Bigner and Johan Ragnar.
Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
